Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...
Severe COVID-19 is defined as SARS-CoV-2 infection with hypoxemia, respiratory distress (respiratory rate >30), and/or severe pneumonia on imaging (>50% infiltrates). 46, 47 Patients with ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The world was transformed by the emergence of SARS-CoV-2, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results